MedTrace Logo

Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus

NCT01973400 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-05-04

No results posted yet for this study

Summary

Given that the tocotrienols have been shown to possess neuroprotective effects and that both type 1 and type 2 diabetes can lead to peripheral neuropathy and cognitive impairment, the present study aims to determine the beneficial effects of tocotrienols in ameliorating such neurological related events in both type 1 and type 2 diabetic patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

Tocotrienol

Palm-Oil derived Vitamin E, tocotrienol

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • Clinical Research Centre, Malaysia

    collaborator OTHER

  • Malaysia Palm Oil Board

    collaborator OTHER_GOV

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Kah Hay Yuen, PhD · Universiti Sains Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2015-09-30
Completion
2016-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01973400 on ClinicalTrials.gov